Nigeria vs South-East Asia (WHO region): New or unknown treatment history cases: Pulmonary, bacteriologically
Nigeria
296,338
in 2023
South-East Asia (WHO region)
1.69 million
in 2023
Nigeria rank
4th
South-East Asia (WHO region) rank
3rd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Nigeria
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 1.69 million against 296,338 in Nigeria, a difference of 1.39 million.
That makes South-East Asia (WHO region)'s figure about 5.7 times Nigeria's.
Across all 11 years both countries report, South-East Asia (WHO region) has been ahead every year.
Nigeria ranks 4th and South-East Asia (WHO region) ranks 3rd of 197 countries.
South-East Asia (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nigeria | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64,466 | 1.25 million | 1.19 million | South-East Asia (WHO region) |
| 2020s | 192,918 | 1.43 million | 1.24 million | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Nigeria or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 1.69 million against 296,338 in Nigeria as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Nigeria and South-East Asia (WHO region)?
- 1.39 million, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for Nigeria and South-East Asia (WHO region)?
- 11 years are reported by both, from 2013 to 2023.
- How do Nigeria and South-East Asia (WHO region) rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Nigeria ranks 4th and South-East Asia (WHO region) ranks 3rd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.